Tumor Biology

Aims & Scope

Tumor Biology is a peer reviewed, international journal providing an open access forum for experimental and clinical cancer research.

Tumor Biology covers all aspects of tumor markers, molecular biomarkers, tumor targeting, and mechanisms of tumor development and progression.

Specific topics of interest include, but are not limited to: Pathway analyses, Non-coding RNAs, Circulating tumor cells, Liquid biopsies, Exosomes, Epigenetics, Cancer stem cells, Tumor immunology and immunotherapy, Tumor microenvironment, Targeted therapies, Therapy resistance Cancer genetics, Cancer risk screening.

Studies in other areas of basic, clinical and translational cancer research are also considered in order to promote connections and discoveries across different disciplines.

The journal publishes original articles, reviews, commentaries and guidelines on tumor marker use.

All submissions are subject to rigorous peer review and are selected on the basis of whether the research is sound and deserves publication.

Tumor Biology is the Official Journal of the International Society of Oncology and BioMarkers (ISOBM).

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,100.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Role of interleukin-6 in cancer progression and therapeutic resistance

  Citation: 863

  Authors: Neeraj, B. S., Asmita, Anant Narayan

• Progress in the treatment of advanced gastric cancer

  Citation: 689

  Authors: Zheyu, Yuanyu, Jiebing, Dingquan, Xuedong

• Radiation-induced cell death mechanisms

  Citation: 521

  Authors: David, Torgny

• Collagen as a double-edged sword in tumor progression

  Citation: 475

  Authors: Min, Jingping, Chunwei, Yan

• Major apoptotic mechanisms and genes involved in apoptosis

  Citation: 474

  Authors: YaÄŸmur, Aysun, Melis, Yusuf

• DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers

  Citation: 367

  Authors: C.S.M., C.S., S.

• Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer

  Citation: 333

  Authors: Qier, Yongfu, Xinjun, Tuo, Min, Lijun, Bojun, Guoliang, Bingxiu, Junming

• Long noncoding RNA: an emerging paradigm of cancer research

  Citation: 302

  Authors: Man-Tang, Jing-Wen, Rong, Lin

• Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets

  Citation: 296

  Authors: Elin, Jan-Olof, Lars

• Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations

  Citation: 280

  Authors: Rafael, Vivian, Arie, Michael J., Roland, Massimo, Helena, Rolf, Marius, György, Petra